Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases

Details for Australian Patent Application No. 2004226823 (hide)

Owner Novartis AG

Inventors Weiss, Carl-Martin; Hirsch, Stefan; Sekkat, Nabila; Grassberger, Maximilian

Agent Davies Collison Cave

Pub. Number AU-A-2004226823

PCT Pub. Number WO2004/087144

Priority 0307869.8 04.04.03 GB

Filing date 2 April 2004

Wipo publication date 14 October 2004

International Classifications

A61K 031/436

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 031/08

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 017/00 Drugs for dermatological disorders

A61K 031/08

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087144 Priority application(s): WO2004/087144

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226824-Quinoline-2-one-derivatives for the treatment of airways diseases

2004226822-Pharmaceutical composition comprising a macrolide immunomodulator